Mutational signatures in squamous cell carcinoma of the lung

BACKGROUND: Tumor mutational burden (TMB) has been identified as one of the predictors for the response to anti-programmed cell death-1 (anti-PD-1) antibody therapy and reported to correlate with smoking history in lung adenocarcinoma. However, in squamous cell carcinoma of the lung, the association...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Thorac Dis
Main Authors: Osoegawa, Atsushi, Takada, Kazuki, Okamoto, Tatsuro, Sato, Seijiro, Nagahashi, Masayuki, Tagawa, Tetsuzo, Tsuchida, Masanori, Oki, Eiji, Okuda, Shujiro, Wakai, Toshifumi, Mori, Masaki
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2021
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7947495/
https://ncbi.nlm.nih.gov/pubmed/33717580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd-20-2602
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares